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N-methyl-D-aspartate receptors (NMDARs) are important to neuron function. 
NMDARs are transmembrane ligand-gated and voltage-gated ion channels that pass 
sodium, potassium, and calcium (MacDermott et al., 1986). They are composed of a 
tetramer of proteins in the postsynaptic cell membrane of neurons. The NMDAR is 
unique in the sense that it requires two agonists to stimulate its activation: the excitatory 
transmitter glutamate, and the co-agonist glycine. It is also unique in voltage-dependent 
regulation via a magnesium block in the ion channel. When the neuron is depolarized, 
this block is removed and ions can pass freely through the channel (Nowak et al., 1984). 
These three properties of passing calcium (MacDermott et al., 1986), being ligand-gated 
by glutamate, and being voltage-gated with a magnesium plug (Nowak et al., 1984), 
make the NMDAR important for regulating activity-dependent postsynaptic plasticity, a 
mechanism believed to underlie learning and memory (Nicoll, 2003). Ionotropic 
activation of NMDARs by ligands has been implicated in extracellular signal-regulated 
kinase (ERK) signaling (Martel et al., 2009). ERK is a protein that promotes synaptic 
plasticity by regulating the membrane trafficking of α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors, which is closely linked to learning and 
memory formation (Sweatt, 2004).  
It is unknown whether NMDARs have a non-ionotropic capacity. My hypothesis 
is that the single NMDAR agonist glycine is capable of regulating ERK activity in the 
absence of ion channel activity. NMDAR activation and coupling to intracellular 
signaling cascades were probed using a pharmacological and molecular biology 
approach. N-methyl-d-aspartate (NMDA) was used to stimulate the receptor at the 




blocked. Cultured mouse neurons and transfected Human Embryonic Kidney (HEK) 293 
cell cultures were used to determine a subunit-specific role of the NMDAR. ERK1 and 
ERK2 phosphorylated protein and total ERK protein were measured using Western blot 
standard procedures (Sambrook and Maniatis, 1989). This research is significant because 
learning how to regulate NMDAR signaling cascades independent of ionotropic activity 
with a single ligand could lead to the development of treatments that could promote 
neuron survival and plasticity in patients with ischemia or neuronal insult.  
The results presented here must be considered inconclusive since there are several 
issues with the experimental protocols, only discovered late in the production of this 
work. While the results cannot be reliably used for any definitive conclusions, they are 
useful in troubleshooting and in refining these procedures. The understanding that these 
experiments have brought can be used to create new experiments that will produce results 






I would like to acknowledge the help of my thesis advisors Dr. Robert Renden 
and Dr. Qi Wan, as well as the help of Brendan Lujan, Lai Wei, and Mingxia Liao, who 
guided and assisted me throughout the production of this thesis. 
This research was made possible by NIH GM103440-11 (INBRE UROP, 
National Institute General Medical Sciences), GM103554 (COBRE Cell Signaling, 




Table of Contents 
Abstract…………………………………………………………………………………….i 
Acknowledgements………………………………………………………………………iii 
Table of Contents……………………………………………………………………..…..iv 










 Neuron Pharmacological Experiment: Proof of Concept…………..……………19 
Neuron Pharmacological Experiment: Blocking Ion Channel Pore and NMDAR  
Glycine Receptors, Testing Overall Response…….....…………………..22 
 HEK293 Control Experiment…..……………..…………………………………23 
 HEK293 Pharmacological Experiment: Blocking Ion Channel Pore and NMDAR  
Glycine Receptors, Testing Subunit-Specific Response………….……...25 
 HEK293 Physiological Experiment: Blocking Ion Channel Pore, Testing Subunit  
Specific Response……………………………………………..…………27 






























List of Figures 
Figure 1: Visual abstract of the intracellular signaling pathways leading to LTD and LTP  
through the NMDAR………………………………………………………..…...10 
Figure 2: NMDAR subunit transfection in HEK293 cells……………………………….15 
Figure 3: NMDAR subunit structures, ligand binding sites, and drug target areas……...19 
Figure 4: Neuronal NMDAR ERK1/2 phosphorylation levels for ionotropic and  
metabotropic controls………………………..…………………………………...21 
Figure 5: Neuronal NMDAR ERK1/2 phosphorylation levels after stimulation with  
NMDA…………………………………………………………………………...21 
Figure 6: Neuronal NMDAR ERK1/2 phosphorylation levels after treatment with L689  
and Ifenprodil and stimulation with NMDA……………………………..………23 
Figure 7: HEK293 transfection efficiency for NMDAR subunits……..………………...24 
Figure 8: ERK1/2 phosphorylation is not a result of a single NMDAR subunit stimulated  
with NMDA ……………………………………………….…………………….25 
Figure 9: ERK1/2 phosphorylation levels after GluN2A and GluN2B NMDAR subunit  
treatment with L689 and Ifenprodil in HEK293 cells…………….……………..26 
Figure 10: ERK1/2 phosphorylation levels of 598M and WT GluN1 subunit NMDARs  
after NMDA stimulation in HEK293 cells…………………...……………….....28 
Figure 11: Western blot of total ERK protein present in a protein concentration dilution  
curve……………………………………………………………………………...29 
Figure 12: Integrated density of T-ERK with a linear regression for the protein  






Ion channels in the cell membrane are crucial to cellular function. The lipid 
bilayer of cell membranes blocks the passive diffusion of ions. Ions can only cross the 
cell membrane via an ion pump or an aqueous pore. Ion pumps actively regulate the 
concentration of specific ions inside and outside of the cell so that a relative negative 
charge within the cell is achieved (Bear et al., 2007). This activity maintains an 
electrochemical gradient across the cell membrane, which creates potential energy that 
the cell utilizes for rapid transmembrane electrical signaling. The difference in voltage 
across the cell is called the membrane potential, which is about -70 mV in neurons, 
relative to extracellular media. These voltages are maintained in a steady state and are 
referred to as the neuron’s resting potential. When ion channels are activated, an aqueous 
pore is formed across the cell membrane, and ions passively diffuse across the cell 
membrane down their individual electrochemical gradients, rapidly changing the relative 
voltage of the cell. These local electrical changes can be propagated within the neuron, 
facilitating intracellular communications (Hodgkin and Huxley, 1952). 
Ion channels can be voltage-gated or ligand-gated. Voltage-gated ion channels are 
regulated by the electrical charge across the cell membrane and open in a voltage-
dependent manner, and may be selective for specific ions. Ligand-gated ion channels are 
regulated by the hydrostatic binding of substances to specific chemical moieties of the 
channel structure. Ligand binding results in a reversible, allosteric change in the physical 
shape of the receptor protein in the cell membrane. This change in shape is what causes 
the ion channel pore to open or close (Campbell, 2009). N-methyl-D-aspartate receptors 




ion permeable channels on the postsynaptic membrane of neurons (MacDermott et al., 
1986), and they exhibit characteristics of both voltage-gated and ligand-gated ion 
channels. NMDARs require the binding of both of the ligands glutamate and glycine at 
separate sites, and cell depolarization to activate the receptor and to open its ion channel 
(Nowak et al., 1984; Bear et al., 2007).  
 The result of ion channel activity can signal the activation of intracellular 
cascades of enzyme activity, modulating protein function. For example, protein kinase 
activation by calcium ions leads to the phosphorylation of a specific target protein, 
transferring a phosphate group from adenosine triphosphate (ATP) to a specific amino 
acid residue on the target protein. Gaining a phosphate group can either activate or 
deactivate that protein due to its resulting change in molecular shape, which in turn can 
regulate other intracellular activity. Other enzymes, acting as phosphatases, reset the 
protein’s activity by removing the phosphate group from the target protein. In this way, 
networks of protein kinase intracellular signaling cascades regulate large-scale changes in 
cellular activity due to specific stimuli, such as patterns of calcium ion influx into the cell 
(Campbell, 2009). 
The synchronized activity of ion channels can also generate massive, rapid 
electrical signaling in neurons. When ion flux causes the membrane potential to 
depolarize to a threshold of about -55 mV, the neuron potential rapidly depolarizes due to 
the activation of voltage-sensitive sodium channels, which permit an explosive flow of 
positive sodium ions across the cell membrane into the cell. This influx of sodium ions 
results in the inside of the cell rapidly becoming positive and depolarizing, peaking at 




activated, and potassium rushes out of the cell, driving the membrane potential towards 
hyperpolarizing potentials. Simultaneously, sodium channels inactivate, and the cell 
hyperpolarizes to around -80mV. ATP-dependent sodium and potassium pumps reset the 
chemical balance of these ions and restore the cell to its resting potential to -70mV 
(Hodgkin and Huxley, 1952). This process is called an action potential, and it diffuses 
rapidly throughout the neuron, which can be up to a meter in length. The frequency and 
pattern of action potentials between neurons is how information is encoded throughout 
the central and peripheral nervous systems (Bear et al., 2007; Campbell, 2009). 
Myelination of neuronal projections speeds the transmission of electrically encoded 
information between different regions of the brain by acting as an insulator for the 
electrical signals (Hodgkin, 1976). The synchronized activity of ion channels plays a 
pivotal role in the generation of and perpetuation of these action potentials in neurons. 
The depolarizing effects of an action potential propagate through the entire 
neuron until the electric current reaches a specialized intercellular contact between two 
neurons, termed a synaptic bouton. The voltage change at the presynaptic site causes an 
influx of calcium, which signals to synaptic vesicles in the bouton to fuse with the 
presynaptic membrane. Synaptic vesicles are small membrane-enclosed pockets that 
contain neurotransmitters. Synaptic vesicles release their contents into the synaptic cleft 
when they fuse with the presynaptic membrane (Sudhof, 2004). These neurotransmitters 
travel across the synaptic cleft to ligand-gated receptors on the postsynaptic cell where 
this chemical signal is converted back into an electrical signal that can be propagated 
through the postsynaptic neuron (Bear et al., 2007; Alberts et al., 2009). This process 




electrical signal in every cell that receives transmitter. This process is used for all 
functions of the brain such as input, information storage, processing, and output. It also 
creates a long-distance signaling mechanism through the nervous system (Bear et al., 
2007; Campbell, 2009).  
NMDARs and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors 
(AMPARs) are ion channels on the postsynaptic membrane of neurons. Glutamate is an 
excitatory neurotransmitter that is released from the presynaptic neuron during an action 
potential, and it binds to both NMDARs and AMPARs. AMPARs are ion channels 
composed of a tetramer of proteins that pass sodium and potassium ions upon activation 
by glutamate binding. They are also capable of passing small amounts of calcium. 
AMPARs contribute to the depolarization of the postsynaptic neuron when they allow the 
passage of these ions across the membrane. NMDARs also pass sodium and potassium 
ions, but they pass significantly greater amounts of calcium than AMPARs (MacDermott 
et al., 1986). NMDARs are different from AMPARs in that they require both glutamate 
and glycine binding, and cell membrane depolarization, to become active. In this way, 
NMDARs become activated when AMPARs contribute to the depolarization of the 
postsynaptic neuron (Bear et al., 2007). Active NMDARs allow calcium into the cell, and 
this calcium influx triggers an intracellular signaling pathway that involves the 
phosphorylation of extracellular-signal regulated kinase (ERK; Martel et al., 2009), 
leading to increased AMPAR trafficking to the cell membrane (Li and Keifer, 2009). 
Measuring the phosphorylation of ERK1 (molecular weight of 44kDa) and ERK2 
(molecular weight of 42kDa) can be used to measure the level of NMDAR activation and 




There is a close relationship between the functions of these two ion channels, and 
their activities are linked to changes in synaptic strength like long-term potentiation 
(LTP) and long-term depression (LTD). Increased synaptic activity in glutamatergic 
neurons leads to the increased function of glutamate receptors like AMPAR (Kauer et al., 
1988; Perkel and Nicoll, 1993). This increased AMPAR function increases NMDAR 
activation, and the resulting calcium influx in turn increases the expression of AMPARs 
on the postsynaptic membrane (Li and Keifer, 2009). Increased expression and 
trafficking of AMPA receptors in and out of the cell membrane are associated with LTP 
(Groc & Choquet, 2006); defined as an increase in synaptic strength, lasting for at least 
an hour (Soderling & Derkach, 2000). In neurons, LTP can be induced by repeated 
correlated presynaptic firing and postsynaptic depolarization, or due to a burst of high-
frequency synaptic activity. Synaptic LTP is associated with behavioral changes in 
learning and memory, and the downregulation of LTP in animal models correlates well 
with loss of memory formation (Nicoll, 2003). Thus, NMDAR activity can be linked to 
AMPA activity and changes in synaptic strength and LTP (Kauer et al., 1988). The 
opposite of LTP is long-term depression (LTD), which is a decrease in synaptic strength 
lasting for at least an hour, and can be thought of as a synaptic correlate to memory 
extinction. This synaptic depression can be induced by the uncorrelated firing of neurons 
or by sustained low-frequency action potential stimulation. Decreased NMDAR activity 
and intracellular calcium concentration initiate a signaling cascade for the removal of 
AMPA receptors from the postsynaptic membrane, decreasing synaptic strength (Bear 
and Malenka, 1994; Bear et al., 2007). Activation of NMDARs and AMPARs initiate 




This study focuses on NMDARs and how they regulate intracellular signaling 
cascades. Preliminary unpublished data from Dr. Wan’s lab have demonstrated that 
glycine alone, the co-agonist of the NMDAR, increases AMPAR receptor function via a 
non-ionotropic signaling capacity of the NMDAR. Non-ionotropic activation of the 
NMDAR to regulate AMPAR function has been shown to be mediated by an ERK-
dependent signaling mechanism. This intracellular mechanism is independent of glycine 
receptor activation in mature hippocampal neurons. Dr. Wan’s lab also has functional 
evidence that glycine alone can activate a non-channel activity of the NMDAR to confer 
neuroprotection in an excitotoxicity model. Non-ionotropic activation of the NMDAR to 
confer neuroprection in the neuronal injury model was shown to be dependent on a 
protein kinase B (AKT) signaling cascade. These findings suggest that ligand binding, 
but not ion flux through the NMDAR, can regulate physiological activity in neurons. 
The work presented here explores these preliminary findings, and attempts to 
validate them using standard protein detection techniques in appropriately controlled 
experiments. The hypothesis for this thesis is that the single agonist glycine can activate 
the NMDAR’s intracellular signaling cascades, regulating ERK1/2 phosphorylation 
independent of the NMDAR’s ionotropic activities. The hypothesis was addressed using 
a pharmacological approach, treating mouse and Human Embryonic Kidney (HEK) 293 
cells in vitro and assaying protein expression with the Western blot technique. A change 
in the expression levels of phosphorylated ERK proteins would indicate that specific 
agonists can regulate NMDAR activity independent of its ionotropic properties. Learning 




single ligand could lead to the development of treatments that could promote neuron 
survival and plasticity in patients with ischemia or neuronal insult. 
 
Literature Review 
N-methyl-d-aspartate receptors (NMDARs) are ion channels on the postsynaptic 
membrane of neurons. They are composed of a tetramer of protein subunits. An obligate 
pair of GluN1 protein subunits associates with GluN2A-D and/or GluN3A-B protein 
subunits to form functional NMDARs. The most common isoforms of the NMDAR 
expressed in mammalian telencephalon (cortex and hippocampus) are composed of the 
GluN2A and GluN2B subunits (Dingledine et al., 1999). The NMDAR is unique in the 
sense that it requires the simultaneous binding of two separate ligands, or agonists, to 
stimulate its activation. The agonist glycine binds to the GluN1 subunit, and the 
coagonist glutamate binds to the GluN2 subunit, regulating channel gating (Laube et al., 
1997). The NMDA receptor also displays characteristics of voltage-dependent activation, 
requiring cell membrane depolarization to remove a magnesium ion residing in the 
channel pore before ions can pass through the channel. Magnesium is present 
physiologically at a 2mM concentration, and it has an electrostatic attraction to the 
NMDA pore protein domain to create a channel plug, much like the stopper in the drain 
of a kitchen sink. Cell membrane depolarization creates a strong enough electrical change 
to repel the magnesium ion out of the channel pore. Cell membrane repolarization drops 
the magnesium plug back into position by electrostatic attraction, blocking the NMDA 




activation is primarily dependent on the removal of this magnesium plug in its ion pore 
(Nowak et al., 1984). 
NMDARs have been implicated in the regulation of synaptic plasticity and 
neuronal survival and death signaling. Greater synaptic activity leads to more NMDAR 
activity and a higher concentration of intracellular calcium (MacDermott et al., 1986), 
which leads to increased α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
receptor (AMPAR) expression and long-term potentiation (LTP; Sweatt, 2004). Lower 
synaptic activity and calcium concentrations have the opposite effect. Thus, the calcium 
concentration within the cell may determine the degree of NMDAR subunit-specific 
activation, leading to either LTP or long-term depression (LTD) promotion (Liu et al., 
2007). The pathological activation of NMDARs can also cause a toxic increase in 
intracellular calcium, which can result in apoptotic cell death. Influencing LTP and LTD 
are how NMDARs regulate synaptic plasticity, and NMDARs play a role in neuronal 
survival and death signaling through their regulation of calcium influx. 
NMDARs have been directly implicated in the mechanisms underlying LTP and 
LTD (Bear and Malenka, 1994). A transient increase in the frequency of action 
potentials, if sufficiently high and/or sustained, makes synaptic connections between two 
neurons stronger by causing an increase in the number of receptors on the receiving 
neuron. This strengthening of neuronal pathways within the brain is induced through the 
exocytosis and endocytosis of cell membrane ion channels (Groc & Choquet, 2006) and, 
when these changes are sustained for at least an hour, is called long-term potentiation 
(LTP; Soderling & Derkach, 2000). When the activity between neurons is not well 




the weakening of synaptic connections through the elimination of receptors on the 
postsynaptic membrane. Extreme instances of LTD can lead to neuronal death, especially 
during early development in neuronal pruning. Eliminating weak pathways leaves room 
for stronger pathways to develop. The global regulation of changes in LTP and LTD 
throughout the nervous system is called metaplasticity, or the plasticity of activity-
induced synaptic plasticity, and acts as a baseline reset for synapses on a longer time 
scale (Abraham and Bear, 1996). Action potentials, cell membrane depolarization, and 
NMDAR activity are all closely linked, and this is why NMDARs are directly implicated 
in the mechanisms underlying LTP and LTD (Bear and Malenka, 1994). 
The GluN2A subunit of the NMDAR is associated with cell survival signaling, 
and the GluN2B subunit is associated with cell death signaling (Liu et al., 2007; Chen et 
al., 2008). NMDA receptors composed of GluN2A subunits are associated with the 
promotion of cell survival and LTP through their upregulation of ERK phosphorylation, 
leading to greater AMPA receptor expression (Liu et al., 2004). Activation of NMDARs 
has been implicated in extracellular-signal-regulated-kinase (ERK) signaling (Martel et 
al., 2009). Calcium ion influx through GluN2A-containing NMDA receptors activates a 
signaling pathway involving calcium/calmodulin-dependent protein kinase II (CaMKII), 
Ras, and ERK1/2 that traffics AMPA receptors into the postsynaptic membrane (Zhu et 
al., 2002). Phosphorylated ERK promotes synaptic plasticity through the regulation of 
intracellular signaling cascades, regulating the AMPA receptor proteins to be trafficked 
to the postsynaptic membrane (Hardingham, Arnold, & Bading, 2001). NMDA receptors 
composed of GluN2B subunits are associated with the inhibition of cell survival, 




2004). Calcium ion influx through GluN2B-containing receptors activates a signaling 
pathway involving Rap and ERK6 that traffics AMPA receptors out of the postsynaptic 
membrane via endocytosis (Zhu et al., 2002). Therefore, the GluN2A subunit is 
associated with cell survival, and the GluN2B subunit is associated with cell death (Liu et 
al., 2007; Chen et al., 2008; Lujan et al., 2012). Figure 1 visually outlines the known 
intracellular signaling pathways that lead to LTP and LTD from the NDMAR.  
Figure 1: Visual abstract of the intracellular signaling pathways leading to LTD and 
LTP through the NMDAR. Calcium influx to the presynaptic bouton triggers the 
release of synaptic vesicles containing glycine (Gly) and glutamate (Glu), which cross the 
synaptic cleft and bind to NMDARs on the postsynaptic membrane. Postsynaptic cell 
depolarization releases the magnesium plug in the NMDAR, allowing calcium into the 
cell. Activation of NMDARs containing the GluN2A subunit leads to the activation of 
CaMKII, which phosphorylates Ras, which phosphorylates ERK1 and ERK2. ERK1 and 
ERK2 traffic AMPARs into the synaptic membrane, which increases LTP. Activation of 
NMDARs containing the GluN2B subunit leads to the phosphorylation of Rap and the 
phosphorylation of ERK6. ERK6 traffics AMPARs out of the synaptic membrane and 





NMDARs can also contribute to a detrimental process of cell death called 
glutamatergic excitotoxicity by allowing too much calcium into the neuron. Apoptosis is 
the controlled destruction of a cell, ensuring that the digestive lysosomal enzymes in the 
cell’s cytoplasm do not leak into the extracellular space to digest and damage 
neighboring, healthy cells. Neuronal injury and the sudden deprivation of blood flow or 
oxygen, as is the case with neuronal insult or ischemia, can result in the unprogrammed 
death of neurons, or necrosis, which has very detrimental results. When neurons 
experience a lack of blood flow and/or oxygen, their metabolic systems cannot function, 
and the neuron cannot produce the ATP needed to maintain its ion pumps and resting 
potential. The resulting break down of the electrochemical gradient causes chronic 
depolarization, allowing calcium to leak into the cell. NMDA receptors play a key role in 
this excitotoxicity process because they are a major route for calcium passage into the 
cell (MacDermott et al., 1986). Unregulated calcium influx triggers the uncontrolled 
release of glutamate, as if repetitive action potentials were occurring. A feedforward 
cycle is propagated throughout the tissue, since the release of glutamate further 
depolarizes neighboring cells, increasing the intracellular concentrations of calcium, and 
triggering the release of still more glutamate. The pathological increase of extracellular 
glutamate, combined with the calcium-induced activation of cellular digestive enzymes 
within the cell, quickly results in neuronal death. This process is called glutamatergic 
excitotoxicity (Bear et al., 2007).  
NMDA receptor activation during excitotoxicity and neuronal pruning has been 
shown to have differing effects on neuronal survival, depending on the subunit 




protect the cell from damage and promote cell survival, whereas NMDARs containing 
the GluN2B subunit seem to promote cell death (Liu et al., 2007; Lujan et al., 2012). The 
localization of specific NMDAR subunits on the cell membrane supports this idea. 
During neural development, GluN2B subunits are expressed on the cell membrane at the 
synapse more than GluN2A subunits, promoting cell death during neuronal pruning. 
Neuronal pruning is the refinement of neuronal pathways through the elimination of weak 
synaptic connections. After neural maturation, the GluN2B subunits relocate from the 
synapse to the edges of the synapse, leaving the GluN2A subunits more prominently 
activated by synaptic activity, and promoting cell survival (Groc and Choquet, 2006). 
Thus the GluN2A subunit protects the cell from damage and promotes cell survival, 
whereas the GluN2B subunit promotes cell death (Liu et al., 2007; Lujan et al., 2012). 
The ionotropic roles of NMDARs are well established (Dingledine et al., 1999), 
but it is not known whether NMDARs possess non-ionotropic activity. NMDARs 
activated ionotropically have been shown to regulate ERK phosphorylation and AMPAR 
expression on the postsynaptic membrane (Krapivinsky et al., 2003; Thomas and 
Huganir, 2004; Kim et al., 2005; Martel et al., 2009), but it is unknown whether any non-
ionotropic activity of NMDARs is involved in the regulation of this process. This study 
focuses on NMDARs and how they regulate the ERK intracellular signaling cascade. 
Preliminary unpublished data from Dr. Wan’s lab have demonstrated that glycine alone, 
the co-agonist of the NMDAR, increases AMPAR receptor function via a non-ionotropic 
signaling capacity of the NMDAR. Non-ionotropic activation of the NMDAR to regulate 
AMPAR function has been shown to be mediated by an ERK-dependent signaling 




mature hippocampal neurons. Dr. Wan’s lab also has functional evidence that glycine 
alone can activate a non-channel activity of the NMDAR to confer neuroprotection in an 
excitotoxicity model. Non-ionotropic activation of the NMDAR to confer neuroprection 
in the neuronal injury model was shown to be dependent on a protein kinase B (AKT) 
signaling cascade. These findings suggest that ligand binding, but not ion flux through 
the NMDAR, can regulate physiological activity in neurons. This study aims to determine 
if NMDARs have non-ionotropic properties that can be activated with the single agonist 




Embryonic mouse neurons from cortex and hippocampus, and cultured Human 
Embryonic Kidney (HEK) 293 cells, were used for this study. Neuronal cells were used 
to look at intracellular kinase regulation due to NMDAR activation, and regulation as a 
result of pharmacological ion channel blockade. All animal experiments were approved 
and carried out in compliance with the guidelines of the Institutional Animal Care and 
Use Committee (IACUC) at the University of Nevada, Reno. A primary in vitro cell 
culture of prenatal hippocampus murine neurons was made from 16-day-old mouse 
embryos. Pregnant C57BL/6 mice were anesthetized by inhalation with isoflurane (Abbot 
Laboratories, North Chicago, IL). Hippocampi from the embryonic mice were isolated in 
ice-cold calcium- and magnesium-free Hank’s balanced salts solution (HBSS; Life 
Technologies, Grand Island, NY) so that no calcium or magnesium ions could interact 




interact with NMDARs. The cells were dissociated into culture dishes, and the neurons 
were allowed to mature for 9 to 11 days in vitro prior to treatment and protein collection, 
using standard culture protocols (Kaech and Banker, 2006). 
HEK293 cells were used to determine the subunit-specific functions of the 
NMDAR. HEK293 cells are a standard tool for molecular transfection and expression of 
ectopic genes. These cells were transfected with specific NMDAR subunits using 
standard procedures (Lipofectamine 2000, Invitrogen) since HEK293  cells do not 
express NMDARs naturally. The expression of specific subunits was manipulated so that 
the role of specific NMDAR functional tetramer subunits could be examined, as is 
represented in Figure 2. HEK293 cells do endogenously express both ERK1/2 (Dong et 
al., 2011) and CaMKII (Tsui et al., 2005), which are the intracellular signaling 
mechanisms manipulated downstream of NDMAR activation. It was necessary to have 
these kinases expressed in HEK293  cells in order to determine if NMDAR activation 
was occurring in the transfected HEK293  cells. The GluN1 598M mutant was used 
because it has a point mutation that substitutes asparagine in position 598 of the protein 
to glutamine (Q) or arginine (R). This amino acid change causes the NMDA receptor’s 
ion channel pore to be malformed, creating a channel block that prevents the voltage-
independent passage of divalent ions like calcium through the channel (Single et al., 
2000). This physical blockade was a different technique used to prevent calcium from 
passing through the NMDAR ion channel and to prevent its ionotropic activity. Levels of 
GluN1, GluN2A, and GluN2B subunit expression were assayed independently to ensure 




the successful expression of functional NMDAR ion channels on the HEK293 cell 
membrane.  
Figure 2: NMDAR subunit transfection in HEK293 cells. Subunits expressed in the 
cytoplasm do not create functional NMDA receptors. Tetramers of subunits comprising a 
pair of GluN1 subunits that are expressed on the cell membrane yield functional NMDA 
receptors that can pass calcium. 
 
Western Blotting 
Cell samples were treated, collected, and prepared for analysis by Western blot, 
all on the same day (see Results). Samples were run through sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) to separate all of the proteins expressed 
in the cells by molecular weight. Afterwards, protein in the gels from SDS-PAGE were 
transferred to a polyvinylidene difluoride (PVDF) membrane (Millipore, Bedford, MA, 
USA) and assayed with an immunoblot technique to measure phosphorylated ERK1/2 
and total ERK1/2 proteins, as well as the presence of NMDAR subunits in transfected 
HEK293  cells. The Western blot assay was performed using standard procedures 




The PVDF membranes were first incubated with primary antibody against 
phosphorylated ERK1 and ERK2 (p-ERK1/2) and, for HEK293 cells, GluN1 (Cell 
Signaling Technology, Beverly, MA). The p-ERK1/2 and GluN1 primary antibodies 
were raised in a rabbit host.  Staining of these primary antibodies was reported with 
horseradish peroxidase-conjugated secondary antibody, and the protein bands were 
imaged using chemiluminescent SuperSignal West Femto Maximum Sensitivity 
Substrate (Pierce, Rockford, IL). An EC3 Imaging System (UVP, LLC, Upland, CA) was 
used to obtain blot images directly from the PVDF membrane. The membrane was then 
stripped and re-probed with primary antibody against total ERK1 and ERK2 protein (t-
ERK1/2) and, for HEK293 cells, GluN2A (Cell Signaling Technology, Beverly, MA) and 
GluN2B (Millipore Corporation, Billerica, MA) subunits. The t-ERK1/2 primary 
antibody was raised in a rabbit host, the GluN2A primary antibody was raised in a goat 
host, and the GluN2B primary antibody was raised in a mouse host. The GluN1 and 
GluN2B primary antibodies were used in a 1:500 ratio in 5% fat free milk in trizma 
buffer saline (TBS) solution. The p-ERK1/2 primary antibody was used in a 1:1500 ratio, 
the t-ERK1/2 primary antibody was used in a 1:1000 ratio, and the GluN2A primary 
antibody was used in a 1:400 ratio. All secondary antibodies were used in ratios as 
recommended by their manufacturers.  
Quantification of the Western blot image data was performed using ImageJ 
software, measuring the integrated optical density of the bands in each trial. A darker 
band in the Western blot indicates a greater density of expressed protein in the sample, 




phosphorylated ERK relative to total ERK is reported as a ratio of p-ERK/t-ERK, and 
this ratio is normalized across trials against a control. 
Materials 
The N-methyl-D-aspartate (NMDA), the Strychnine, and the glycine used for 
these experiments were from Sigma-Aldrich (St. Louis, MO). MK-801, Ifenprodil, and 
L689 were from Tocris Biosciences (Ellisville, MO). 
Statistics 
The ratio of the integrated optical densities of phosphorylated ERK to total ERK 
proteins was taken for every trial, and the mean of all trials was graphed. A minimum of 
three replicates showing the same result was considered sufficient to draw conclusions, as 
is consistent with accepted practice in the field. An ANOVA was used to examine the 
statistical significance of the differences between groups of data using GraphPad Prism 




 Changes in ERK1/2 intracellular signaling due to NMDAR activation were 
probed using pharmacological and physiological approaches. The possibility for calcium 
to pass through the ion channel was eliminated by treating the cells in a calcium free 
extracellular solution (ECS) containing ethylene glycol tetraacetic acid (EGTA) 
(Research Organics, Cleveland, OH), which binds to divalent cations such as calcium and 
magnesium, making these ions unavailable for interaction with the NMDAR (Auld, 




permanently blocked the ion channel pore of the NMDAR, to prevent ionotropic 
activation. In experimental pre-treatment protocols, cells treated with MK-801 were 
stimulated with glycine and NMDA to remove this magnesium plug so that the plug 
could be replaced with MK-801, creating a receptor that was pharmacologically blocked 
and no longer ionotropically functional. Cell cultures were stimulated with N-methyl-D-
aspartate (NMDA; 50µM), a synthetic agonist replacement for glutamate that is specific 
to the NMDA receptor ligand-binding site for glutamate. A synthetic agonist was used 
because it specifically targets the activation site of interest on the GluN2 subunit of the 
NMDAR. Strychnine (10µM) was used as a glycine receptor antagonist, blocking 
peripheral glycine receptor activation on the cell membrane. L689 (5µM) is a drug that 
blocks the primary glycine-binding site on the GluN1 subunit of the NMDAR. Ifenprodil 
(10µM) is a drug that blocks the glycine-binding site on the GluN2 subunit, with a higher 
affinity for the GluN2B subunit of the NMDAR. Refer to Figure 3 for a schematic of the 
























Figure 3: NMDAR subunit structures, ligand binding sites, and drug target areas. 
Glycine binds to the GluN1 subunit and glutamate binds to the GluN2 subunit. Ifenprodil 
(10µM) blocks the peripheral glycine-binding site on GluN2, with a higher affinity for 
GluN2B. L689 (5µM) blocks the primary glycine-binding site on GluN1. MK-801 
(10µM) permanently pharmacologically blocks the ion channel pore after NMDAR 
activation removes the magnesium plug in the ion channel (adapted from Siegler, 
Retchless et al., 2012). 
 
Neuron Pharmacological Experiment: Proof of Concept 
 The hypothesis for this experiment was that NMDAR activation could occur non-
ionotropically, resulting in the phosphorylation of ERK1/2. This treatment compared 
neurons stimulated with NMDA (50µM) in ionotropic conditions versus metabotropic 
conditions. Experimental conditions consisted of both normal extracellular solution 
(ECS) and calcium-free ECS, with each condition consisting of both MK-801 (10µM) 
blocked channel treatments and MK-801 free treatments. All treatments contained 
strychnine (10µM). Phosphorylated ERK1/2 was measured against total ERK1/2 protein. 




glutamate was necessary to stimulate the phosphorylation of ERK1/2 through the NMDA 
receptor. They also found, at minimum, a two-fold increase in ERK1/2 phosphorylation 
levels in striatal cells over conditions not containing extracellular calcium or glutamate. 
A two-fold increase in phosphorylated ERK1/2 was therefore expected in the normal 
ECS, MK-801 free, NMDA-stimulated condition over the non-stimulated condition for 
this experiment. A 0.5-fold increase was expected in non-ionotropic NMDA-stimulated 
conditions (i.e. in the presence of MK-801 or calcium-free ECS) over non-stimulated 
conditions consistent with preliminary data in Dr. Wan’s lab. 
 Figure 4 shows the control results for neurons not stimulated with NMDA. There 
was no significant difference between the baseline ERK1/2 phosphorylation levels for 
ionotropic channel activation of the NMDAR versus metabotropic, non-channel 
activation. Figure 5 shows the normalized ERK1/2 phosphorylation levels after 
stimulating NMDARs with NMDA. There were no significant differences in 
phosphorylation between treatment and control groups, and there were no significant 








Figure 4: Neuronal NMDAR ERK1/2 phosphorylation levels for ionotropic and 
metabotropic controls. Samples were not stimulated with NMDA, and ion channels 
were blocked with MK-801 (10µM) in metabotropic controls only. NMDAR ionotropic 
and metabotropic activities were measured by assaying ERK1/2 phosphorylation against 
total ERK1/2 protein using Western blot. When ionotropic activity was inhibited, there 
was less ERK phosphorylation. However, these differences were not significant. 
 
 
Figure 5: Neuronal NMDAR ERK1/2 phosphorylation levels after stimulation with 
NMDA. Ion channels were blocked with MK-801 (10µM). NMDAR ionotropic and 
metabotropic activities were measured by assaying ERK1/2 phosphorylation against total 
ERK protein after treatment with NMDA (50µM) using Western blot. No significant 
differences were found between treatment with NMDA and controls, nor between 
ionotropic and metabotropic activities. Results are normalized to a negative control with 







Normal	  ECS,	  No	  
MK-­‐801	  
Normal	  ECS	  w/o	  Mg
++,	  No	  MK-­‐801	  
Normal	  ECS,	  MK-­‐801	   Ca++	  Free	  ECS,	  
MK-­‐801	  
N=8	   N=4	   N=3	   N=18	  














NMDA	   NMDA	   NMDA	   NMDA	  
Negative	  Control	   Normal	  ECS,	  No	  
MK-­‐801	  





Ca++	  Free	  ECS,	  
MK-­‐801	  
N=8	   N=4	   N=3	   N=18	  










Neuron Pharmacological Experiment: Blocking Ion Channel Pore and NMDAR Glycine 
Receptors, Testing Overall Response 
 The hypothesis for this experiment was that NMDAR activation could occur non-
ionotropically via a secondary glycine-binding site on the GluN2 subunit, resulting in the 
phosphorylation of ERK1/2. This experiment was designed to try to describe where 
glycine is binding in order to activate the NMDAR, if the primary receptor site on the 
GluN1 subunit was not responsible for ERK1/2 phosphorylation. Conditions for this 
experiment consisted of calcium-free ECS with MK-801 (10µM) blocked channel 
treatments and strychnine (10µM). Experimental conditions included L689 (5µM) to 
block the primary glycine-binding site on the GluN1 subunit, Ifenprodil (10µM) to block 
the hypothesized secondary glycine-binding site on the GluN2 subunit, and then both 
L689 (5µM) and Ifenprodil (10µM). Phosphorylated ERK1/2 was measured against total 
ERK1/2 protein in all conditions. No significant increase in ERK1/2 phosphorylation 
levels was expected in the control condition or in the Ifenprodil conditions. A 0.5-fold 
increase was expected in the L689, NMDA (50µM) condition, based on Dr. Wan’s 
preliminary data showing metabotropic activation. Figure 6 shows that ERK1/2 
phosphorylation levels through NMDAR metabotropic activities are not significantly 





Figure 6: Neuronal NMDAR ERK1/2 phosphorylation levels after treatment with 
L689 and Ifenprodil and stimulation with NMDA. Calcium-free ECS was used, and 
ion channels were blocked with MK-801 (10µM). L689 (5µM) and Ifenprodil (10µM) 
were used to block glycine binding. NMDAR metabotropic activities were measured by 
assaying ERK1/2 phosphorylation after treatment with NMDA (50µM) with Western 
blot. No significant differences were found between treatment with NMDA and controls, 
and no significant difference was found between drug treatments. Results are normalized 
to a negative control with no NMDA stimulation. 
 
HEK293 Control Experiment 
 This experiment was designed to show that the NMDAR subunits were being 
successfully transfected into the HEK293 cells, that ERK1/2 phosphorylation was not the 
result of a single NMDAR subunit acting by itself, and that ERK1/2 phosphorylation is 
not a result of NMDA-stimulated cellular activity outside of the NMDAR. A negative 
result was hypothesized, showing no significant ERK1/2 phosphorylation above the 
negative control without NMDA stimulation. Four transfection conditions were evaluated 
in calcium-free ECS with MK-801 (10µM) and strychnine (10µM). The four conditions 
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transfection only, and GluN2B transfection only. Phosphorylated ERK1/2 was measured 
against total ERK1/2 protein, and the presence of the GluN1, GluN2A, and GluN2B 
subunits was assayed. Figure 7 shows that the subunits were transfected successfully, 
though the faint presence of bands in HEK293 cells not transfected for the GluN2A and 
GluN2B subunits suggest that HEK293 cells may have some endogenous NMDAR 
proteins. It is also possible that some nonspecific antibody binding occurred giving a 
false result. Figure 8 shows that the HEK293 cells stimulated with NMDA (50µM) did 
not have a significant increase in ERK phosphorylation when compared to the HEK293 
cells not stimulated with NMDA, demonstrating that a single NMDAR subunit is not 
sufficient to phosphorylate ERK1/2. 
Figure 7: HEK293 transfection efficiency for NMDAR subunits. The GluN1, 
GluN2A, and GluN2B subunits were successfully transfected and expressed in every 
trial. The GluN1 row is representative of both the WT and 598M GluN1 subunit types. 
There appears to be either some nonspecific antibody binding or some endogenous 






Figure 8: ERK1/2 phosphorylation is not a result of a single NMDAR subunit 
stimulated with NMDA. HEK293 cells were transfected with no NMDAR subunits, 
GluN1 subunit only, GluN2A subunit only, or GluN2B subunit only. ERK1/2 
phosphorylation levels were measured against total ERK protein. No significant 
differences were found between cells stimulated with NMDA (50µM) and non-stimulated 
cells. Results are normalized to a negative control with no NMDA stimulation. 
 
HEK293 Pharmacological Experiment: Blocking Ion Channel Pore and NMDAR Glycine 
Receptors, Testing Subunit-Specific Response 
 The hypothesis for this experiment was that NMDAR activation could occur non-
ionotropically via a secondary glycine-binding site, resulting in the phosphorylation of 
ERK1/2. HEK293 cells were transfected with a combination of GluN1 plus GluN2A 
subunits, or of GluN1 plus GluN2B subunits. Conditions for this experiment consisted of 
calcium-free ECS with strychnine (10µM) and MK-801(10µM) blocked channel 
treatments. Experimental conditions included L689 (5µM) to block the primary glycine-
binding site on the GluN1 subunit, or Ifenprodil (10µM) to block the hypothesized 
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measured against total ERK1/2 protein in all conditions. No significant increase in 
ERK1/2 phosphorylation levels was expected in the control condition and in the 
Ifenprodil conditions. A 0.5-fold increase was expected in the L689, NMDA (50µM) 
condition, based on Dr. Wan’s preliminary data. Figure 9 shows that NMDARs 
containing GluN2A or GluN2B subunits do not have activities significantly affected by 
antagonizing glycine binding with L689 or Ifenprodil. No significant differences were 
found between treatment with NMDA and controls, and no significant differences were 
found between cells expressing receptors composed of the GluN2A or GluN2B subunits. 
 
Figure 9: ERK1/2 phosphorylation levels after GluN2A and GluN2B NMDAR 
subunit treatment with L689 and Ifenprodil in HEK293 cells. HEK293 cells were 
transfected with GluN1 plus GluN2A or GluN2B NMDAR subunits. Calcium was made 
unavailable for passage through the NMDAR ion channel with calcium-free ECS, and ion 
channels were blocked with MK-801 (10µM). L689 (5µM) and Ifenprodil (10µM) were 
used to block glycine binding. NMDAR metabotropic activities were measured by 
assaying ERK1/2 phosphorylation after treatment with NMDA (50µM) using Western 
blot. No significant differences were found between treatment with NMDA and controls. 
No significant difference was found between drug treatments. No significant differences 
were found between cells expressing receptors composed of the GluN2A or GluN2B 
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HEK293 Physiological Experiment: Molecular Block of Ion Channel Pore, Testing 
Subunit-Specific Response 
 This experiment was designed to determine if there were any NMDAR subunit-
specific correlations for non-ionotropic ERK1/2 phosphorylation. HEK293 cells were 
transfected with a combination of GluN1 mutant 598M plus GluN2A subunits; Wild 
Type (WT) GluN1 plus GluN2A subunits; GluN1 mutant 598M plus GluN2B subunits; 
or WT GluN1 plus GluN2B subunits. The GluN1 598M mutant has a point mutation that 
substitutes asparagine in position 598 of the protein to glutamine (Q) or arginine (R). 
This amino acid change causes the receptor’s ion channel pore to be malformed, creating 
a channel block that prevents the voltage-independent passage of divalent ions like 
calcium through the channel (Single et al., 2000). Using the 598M mutant physiologically 
prevents ionotropic activation of the NMDAR, similar to how MK-801 
pharmacologically blocks ionotropic activation of the NMDAR by permanently replacing 
the magnesium plug in the ion channel. Conditions for this experiment consisted of 
calcium-free ECS and strychnine (10µM), further creating a non-ionotropic, metabotropic 
activation environment for the NMDA receptors. Metabotropic, subunit-specific 
activation of the NMDAR was being tested.  
Phosphorylated ERK1/2 was measured against total ERK1/2 protein in all 
conditions. A greater increase in ERK1/2 phosphorylation was expected in the NMDA 
(50µM) stimulated conditions than in the non-stimulated conditions. Figure 10 shows 
that, after metabotropic activation, there were no significant differences in ERK1/2 
phosphorylation levels of NMDARs containing GluN2A versus GluN2B subunits. 




GluN1 subunit did not yield a significant difference in ERK1/2 phosphorylation levels 
when compared to Wild Type (WT) GluN1 metabotropic activation. 
 
Figure 10: ERK1/2 phosphorylation levels of 598M and WT GluN1 subunit 
NMDARs after NMDA stimulation in HEK293 cells. HEK293 cells were transfected 
with Wild Type (WT) or 598M mutant GluN1 NMDAR subunits plus GluN2A or 
GluN2B subunits. The 598M subunits physically blocked the NMDAR ion channel pore. 
Calcium was made unavailable for passage through the ion channel with calcium-free 
ECS. NMDAR metabotropic activities were measured by assaying ERK1/2 
phosphorylation after treatment with NMDA (50µM) using Western blot. No significant 
differences were found between treatment with NMDA and controls, and no significant 
differences were found between WT and 598M transfected HEK293 cells, with either 
GluN2A or GluN2B subunits. Results are normalized to a negative control with no 
NMDA stimulation. 
 
Protein Concentration Dilution Curve 
 This experiment was conducted after analyses of the previous experiments 
showed insignificant results. The purpose of this experiment was to show that I am 
capable of completing the Western blot successfully, thus demonstrating that the results 
in my previous experiments were indeed accurate and not the result of poor technique. A 
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concentration curve. Gel wells were filled with brain tissue samples containing total 
protein concentrations of 0.5 - 40 µg/µl, and the Western blot was conducted to assay for 
total ERK1/2 protein. Two samples from the same culture were run, and Figure 11 shows 
the Western blot results of the second run showing a clear dilution curve. The results for 
the 30µg/µl and 40µg/µl samples in the first Western blot were faulty and were therefore 
not included. Analysis of the bands in ImageJ yielded the pixel integrated densities of 
each sample, and these values were plotted along both a linear scale and a logarithmic 
scale, as can be seen in Figure 12. The top graph plots the results along a linear scale, and 
a logarithmic function fits the mean results with an equation of y=1.6561ln(x) + 2.0973 
and R2=0.9819. The bottom graph plots the results along a logarithmic scale, and a linear 
function fits the mean results with an equation of y=1.6561(x) + 2.0973 and R2=0.9819. 
These results indicate data with a strong fit to the regression lines, as is indicated by how 
the R2 value is so close to 1. Such a strong fit is indicative of a reliable result for the 
standard curve. 
Figure 11: Western blot of total ERK1/2 protein present in a protein concentration 
dilution curve. A mouse cortical brain tissue sample was diluted to create a 
concentration curve. This is a successful, clean Western blot result showing the steady 







Figure 12: Integrated density of t-ERK1/2 with a best-fit function for the protein 
concentration dilution curve. The integrated densities of two Western blots containing 
dilutions of a mouse cortical brain tissue sample create a dilution curve. The results for 
the 30µg/µl and 40µg/µl samples in the first Western blot were faulty and therefore not 
included. The top graph plots the results along a linear scale, and a logarithmic function 
results along their mean with an equation of y=1.6561ln(x) + 2.0973 and R2=0.9819. The 
bottom graph plots the results along a logarithmic scale, and a linear function results 




	   The	  neuron	  pharmacological	  proof-­‐of-­‐concept	  experiment	  was	  meant	  to	  be	  a	  
positive	  control	  experiment	  providing	  a	  baseline	  of	  ERK1/2	  phosphorylation	  levels	  
in	  both	  physiological	  ionotropic	  conditions	  and	  non-­‐ionotropic	  conditions.	  Though	  
the	  differences	  in	  phosphorylation	  levels	  across	  conditions	  were	  not	  significant,	  an	  
expected	  pattern	  of	  phosphorylation	  was	  generally	  observed,	  as	  is	  depicted	  in	  
y	  =	  1.6561ln(x)	  +	  2.0973	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Figure	  4.	  In	  the	  ionotropic	  controls,	  there	  was	  greater	  ERK1/2	  phosphorylation	  in	  
the	  magnesium-­‐free	  ECS	  condition	  than	  in	  the	  normal	  ECS	  condition.	  This	  makes	  
sense	  since	  a	  shortage	  of	  free	  magnesium	  available	  to	  plug	  the	  NMDAR	  ion	  pore	  
would	  result	  in	  ion	  channels	  that	  are	  free	  to	  pass	  calcium,	  independent	  of	  cell	  
depolarization.	  The	  magnesium-­‐free	  condition	  represents	  NMDAR	  activation	  levels,	  
and	  thus	  ERK1/2	  phosphorylation	  levels,	  higher	  than	  what	  is	  likely	  to	  happen	  in	  
normal,	  physiological	  conditions.	  The	  metabotropic	  conditions	  were	  expected	  to	  
have	  less	  phosphorylation	  than	  the	  ionotropic	  conditions,	  and	  this	  is	  seen	  in	  the	  
normal	  ECS,	  MK-­‐801	  (10µM)	  condition,	  where	  MK-­‐801	  is	  blocking	  the	  NMDAR	  ion	  
pore	  and	  preventing	  calcium	  passage.	  The	  calcium-­‐free	  ECS,	  MK-­‐801	  condition	  
should	  have	  had	  lower	  phosphorylation	  levels	  still,	  since	  there	  was	  no	  calcium	  
available	  to	  pass	  through	  the	  ion	  channel,	  which	  was	  blocked	  by	  MK-­‐801,	  anyway.	  
However,	  this	  condition	  appears	  to	  have	  phosphorylation	  levels	  comparable	  to	  the	  
normal,	  ionotropic	  condition.	  This	  was	  unexpected,	  and	  it	  can	  perhaps	  be	  explained	  
by	  how	  large	  the	  error	  bar	  is,	  suggesting	  that	  there	  were	  issues	  with	  reproducibility.	  
	   These	  same	  conditions	  were	  then	  stimulated	  with	  NMDA	  (50µM),	  presented	  
in	  Figure	  5.	  The	  ionotropic	  conditions	  did	  not	  show	  the	  expected	  two-­‐fold	  increase	  
in	  ERK1/2	  phosphorylation	  over	  the	  non-­‐stimulated	  condition	  (Schwarzschild et al.,	  
1999).	  This	  was	  a	  troubling	  finding,	  and	  it	  is	  perhaps	  due	  to	  the	  small	  sample	  size	  
and	  the	  large	  degree	  of	  error	  showing	  difficulty	  in	  reproducibility.	  However,	  the	  
metabotropic	  conditions	  did	  show	  the	  expected	  minimum	  0.5-­‐fold	  increase	  that	  was	  




showed	  that	  metabotropic	  activation	  of	  the	  NMDAR	  is	  possible	  and	  predictably	  
measureable.	  
The neuron pharmacological experiment that used L689 (5µM) and Ifenprodil 
(10µM) was meant to determine if glycine binding played a role in the metabotropic 
phosphorylation of ERK1/2 in the NDMAR (Figure 6). Since	  there	  were	  no	  significant	  
differences	  in	  ERK1/2	  phosphorylation	  across	  all	  experimental	  conditions,	  this	  
would	  suggest	  that	  glycine	  binding	  might	  not	  effect	  metabotropic	  activation	  of	  the	  
NMDA	  receptor.	  However,	  since	  there	  are	  so	  many	  issues	  with	  the	  experimental	  
protocols,	  I	  cannot	  confidently	  make	  this	  conclusion.	  I	  do	  not	  feel	  that	  I	  was	  able	  to	  
reliably	  detect	  changes	  in	  phosphorylation	  levels,	  even	  if	  they	  had	  been	  present.	  The	  
results	  for	  this	  experiment	  are	  inconclusive,	  and	  the	  experiment	  should	  be	  repeated	  
with	  improved	  procedures.	  
The HEK293 control experiment was meant to demonstrate that there was 
successful HEK293 transfection of NMDAR subunits and that valid NMDAR subunit 
experiments could be conducted in HEK293 cells. It was also meant to show that ERK1/2 
phosphorylation is not the result of a single NMDAR subunit acting by itself, and that 
ERK1/2 phosphorylation is not a result of NMDA-stimulated cellular activity outside of 
the NMDAR. Figure 7 shows the Western blot results of NMDAR subunit assays, 
proving that the HEK293 transfections were successful. There appears to either be 
endogenous GluN2A and GluN2B subunit protein in the HEK293 cells, or nonspecific 
binding of the antibodies in the Western blot procedure giving a false positive result. The 
ERK1/2 phosphorylation results in Figure 8 show there is no significant difference in 




appear to be slightly higher phosphorylation levels in the GluN1-only transfection 
condition. This observation combined with the Western blot results suggests that there 
are endogenous NMDAR subunit proteins being expressed in HEK293 cells. Although, if 
there are GluN2A and GluN2B NMDAR subunits being endogenously expressed in 
HEK293 cells, they are not being expressed at a high enough level to significantly impact 
the results of the experiments being conducted in HEK293 cells. 
 The HEK293 pharmacological experiment involving Ifenprodil (10µM) and L689 
(5µM) was meant to determine if there are any subunit-specific functions of the NMDAR 
in ERK1/2 phosphorylation. HEK293 cells were transfected with combinations of either 
GluN1 plus GluN2A subunits, or GluN1 plus GluN2B subunits, and then treated in 
calcium-free ECS and MK-801 (10µM) to create a metabotropic condition. L689 and 
Ifenprodil are glycine-binding inhibitors for the GluN1 and GuN2 subunits, respectively, 
with Ifenprodil having a slightly higher affinity for the GluN2B subunit. The results of 
this experiment are depicted in Figure 9. Despite the lack of significant difference in 
results between the experimental conditions, it appears that Ifenprodil had a greater 
inhibitory effect on ERK1/2 phosphorylation than L689. It also looks like GluN2B 
subunits had less phosphorylation than GluN2A subunits overall. This makes sense since 
Ifenprodil has a higher affinity for the GluN2B subunit, inhibiting its activity more than 
the GluN2A subunit. The only 0.5-fold increase in ERK1/2 phosphorylation levels 
observed was in the GluN1 plus GluN2A, Ifenprodil experimental condition. This 
suggests that metabotropic activation of the NMDAR is only possible in the receptors 
composed of the GluN2A subunit, and that glycine binding to the GluN2A subunit is 




 The HEK293 physiological experiment involved physically blocking the 
NMDAR ion channel pore with the GluN1 598M subunit mutant. This experiment was 
meant to determine if there were any subunit-specific of the NMDAR in ERK1/2 
phosphorylation. Physically blocking the ion channel and treating the cells in calcium-
free ECS created a metabotropic environment for the HEK293 cells transfected with 
combinations of GluN1 598M plus GluN2A, or GluN1 598M plus GluN2B NMDAR 
subunits. The results of this experiment are seen in Figure 10. While there are no 
significant differences in ERK1/2 phosphorylation levels between any of the 
experimental conditions, there does appear to be greater phosphorylation in the GluN1 
598M mutant NMDA receptors than in the WT receptors. 
The HEK293  cell transfection experiments may be considered valid because the 
HEK293  cells are an appropriate model for NMDAR experiments. HEK293  cells must 
be transfected in order to express NMDAR subunits, and they do endogenously express 
ERK1/2 (Dong et al., 2011) and slight levels of CaMKII (Tsui et al., 2005). Since 
ERK1/2 and CaMKII are the intracellular signaling mechanisms manipulated 
downstream of NDMAR activation, it is necessary to have these kinases expressed in 
HEK293  cells in order to determine if NMDAR activation is occurring in the transfected 
HEK293  cells. The measure of phosphorylated ERK1/2 protein demonstrates the 
successful expression of functional NMDAR ion channels on the HEK293 cell 
membrane. Since these mechanisms are present, all of the HEK293  cell experiments 
with the NMDA receptor can be considered valid.  
Because no significant results were found in the proceeding experiments, a 




was being conducted correctly. This experiment was demonstrates that I can prepare 
experimental samples, accurately assess and dilute those samples’ overall protein levels, 
and complete the Western blot properly to yield clear, analyzable results. This experiment 
was conducted as a necessary troubleshoot to eliminate the possibility that the preceding 
insignificant results were due to failed technique. Adult mouse cortical brain tissue 
samples were prepared, and total ERK1/2 protein was assayed. Two samples were run, 
and Figure 11 shows the Western blot results of the second run showing a clear dilution 
curve. The results for the 30µg/µl and 40µg/µl samples in the first Western blot were 
faulty and were therefore not included. This suggests that reproducibility becomes more 
difficult at these higher protein concentrations. The integrated densities of each sample 
were plotted along both a linear scale and a logarithmic scale, as can be seen in Figure 
12. The top graph plots the results along a linear scale, and is fit by a logarithmic 
function, reflecting expected signal response from the antibody staining technique. The 
bottom graph plots the results along a logarithmic scale, and is fit by a linear function 
with an equation of y=1.6561(x) + 2.0973 and R2=0.9819. The regression lines for both 
graphs have a very high fit to the data with R2=0.9819, indicating that there is little 
variance between runs and a high degree of reproducibility. The clarity of the results and 
their reproducibility show that I am proficient at the Western blot technique and that the 
results are not insignificant due to failed technique. 
When looking at the protein concentration dilution curve plotted in Figure 12, it 
becomes apparent that using a sample concentration of 40µg/µl for these experiments 
may not have been ideal. The samples with a concentration of 30µg/µl and 40µg/µl were 




is a diminishing slope. This means that a two-fold increase in phosphorylated ERK1/2 
protein concentration at these sample concentrations would be less apparent and more 
difficult to detect. However, at sample concentrations between 10µg/µl and 20µg/µl, 
changes in protein concentrations along the logarithmic regression line are more drastic. 
A two-fold increase in protein concentration is easy to detect along this part of the 
standard curve because it correlates with the largest difference in integrated density. 
Since a two-fold increase in phosphorylated ERK1/2 levels between NMDA-stimulated 
and non-stimulated conditions is expected in the experiments (Schwarzchild et al., 1999), 
I would recommend using a protein concentration between 10µg/µl and 20µg/µl for the 
experimental samples. This concentration range would be ideal and sufficient to see the 
expected results in a neuron positive control, and it would give an adequate and 
measurable range of potential protein expression to each experimental condition. 
In addition, I recommend that a p-ERK1/2 primary antibody dilution curve should 
be run on samples using this new recommended sample concentration range of 10µg/µl 
to 20µg/µl. Running a dilution curve using the new sample concentrations will help to 
find the ideal concentration of p-ERK1/2 primary antibody that should be used in future 
experiments. Having an antibody concentration high enough to detect the presence of the 
desired protein, yet not too high so as to saturate the image, is important because 
saturating the image will convolute the analysis conducted with ImageJ. The artificially 
high pixel integrated density values produced in ImageJ will make it seem that there are 
higher concentrations of protein present than there truly are. Using the proper 




density values produced more accurately reflect the actual p-ERK1/2 protein 
concentrations in each sample. 
NMDAR metabotropic activation leading to ERK1/2 phosphorylation was not 
shown at significant levels in these experiments. However, there are enough issues with 
the experimental protocol that these results may be considered inconclusive. These results 
cannot be reliably used for any definitive conclusions, but they are useful in 
troubleshooting and in refining the procedures. The understanding that these experiments 
have brought can be used to create new experiments with altered protocols that will 
produce results that can be reliably assessed. These new results may then be used to 
address the hypothesis. 
Creating a reproducible positive control with anticipated results that are consistent 
with previous knowledge is important to establish before moving forward with 
experiments. This was not done adequately for these experiments. The neuron positive 
controls seen in Figures 4 and 5 show favorable patterns of ERK1/2 expression, but they 
do not show the differential levels of ERK1/2 expression that are consistent with previous 
knowledge. The minimum two-fold increase in phosphorylated ERK1/2 between non-
stimulated and NMDA-stimulated conditions, as was seen by Schwarzchild et al. in 1999, 
is not observed in this positive control. This baseline needs to be better established in 
future experiments. The experimental protocol needs to be troubleshot and altered 
sufficiently to create these expected results before any experimental conditions can be 
rerun. Without these necessary alterations, any results seen in future experimental 





For the HEK293 experiments, I would suggest including experimental conditions 
that are conducted in normal ECS. This would create an ionotropic condition that the 
metabotropic conditions can be compared against, looking for that 0.5-fold increase in 
phosphorylated ERK1/2 protein that was previously observed in Dr. Wan’s lab.  
Even if further experimentation does yield reliable results that conclusively refute 
the hypothesis, this would not suggest that the NDMAR could not be metabotropically 
activated. It is still true that metabotropic activation of the NDMAR could lead to the 
activation of another intracellular signaling cascade that does not include the 
phosphorylation of ERK1/2. Future Western blot studies could investigate this idea, 
measuring the phosphorylation of other proteins in NMDAR intracellular signaling 
cascades under metabotropic conditions. For example, Nabavi et al. (2013) found 
metabotropic activation of the NMDA receptor by measuring phosphorylated p38 MAP 
kinase against total p38 using the Western blot. They concluded that ligand binding to the 
NMDA receptor under basal calcium conditions was sufficient to induce LTD, and that 
ion flux through the ion pore was not necessary.  
Additionally, experiments involving other techniques measuring things that the 
Western blot cannot measure could show that NMDAR metabotropic activation is 
occurring. For example, immunohistochemistry staining of AMPA receptors could show 
visual changes in AMPAR expression levels under different NMDAR activation 
conditions. Also, patch clamp experiments measuring local changes in the cell membrane 
potential at the postsynaptic membrane could be used to demonstrate that NMDAR 
activity is occurring in metabotropic conditions. For example, Nabavi et al. (2013) were 




stimulation using the patch clamp technique. Similarly, Kessels et al. (2013) used the 
patch clamp technique to take field potential recordings of neurons, measuring AMPAR 
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